Press "Enter" to skip to content

Posts tagged as “Metastatic”

Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma – BioSpace

admin 0

Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma  BioSpace “cervical cancer” –…

Trastuzumab deruxtecan granted FDA priority review to treat patients with HER2-positive metastatic breast cancer – Pharmaceutical Business Review

admin 0

Trastuzumab deruxtecan granted FDA priority review to treat patients with HER2-positive metastatic breast cancer  Pharmaceutical Business Review “colorectal cancer” – Google News

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer – BioSpace

admin 0

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer  BioSpace “colorectal cancer” – Google News

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer – PRNewswire

admin 0

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer  PRNewswire “colorectal cancer” – Google News

[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients With HER2-positive Metastatic Breast Cancer | Antibodies | News Channels – PipelineReview.com

admin 0

[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients With HER2-positive Metastatic Breast Cancer | Antibodies | News Channels  PipelineReview.com “colorectal cancer” – Google News

[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients With HER2-positive Metastatic Breast Cancer – Business Wire

admin 0

[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients With HER2-positive Metastatic Breast Cancer  Business Wire “colorectal cancer” – Google News